Professor, Medicine, Tufts Medical Center
Cardiology
Dr. Richard W. Nesto, MD
|
|
Give Review
Richard W. Nesto works in the field of Cardiology. He went to medical school at Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He has 4 awards "Boston Magazine", "Fellow (FACC)", "Top MD" and "Super Doctor". Richard Nesto has written publications. He has 53 publications published with PubMed. The lastest publication is: 'Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI ...' Richard W. Nesto accepts Medicare payments and is listed with Medicare.gov.
Publications
- Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI ...
- Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care.
- Cardiac Resynchronization Therapy Reduces the Risk of Cardiac Events in Patients with Diabetes Enrolled in the MADIT-CRT Trial.
- Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insu...
- Influence of diabetes and/or myocardial infarction on prevalence of abnormal T-wave alternans.
- Clinical characteristics of tako-tsubo cardiomyopathy.
- In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
- Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Ca...
- Editorial: What have we lost in the wake of the rosiglitazone controversy?
- Type 2 diabetes and coronary heart disease: focus on myocardial infarction.
- The "legacy effect" associated with intensive glucose control in patients with type 2 diabetes.
- Guiding clinical decisions on abdominal obesity and cardiometabolic risk.
- Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline ...
- Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endo...
- Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.
- Glucose: a biomarker in acute myocardial infarction ready for prime time?
- Grand rounds: asbestos-related pericarditis in a boiler operator.
- Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.
- Myocardial glucose transport and utilization: a target for therapeutic intervention.
- High yellow color intensity by angioscopy with quantitative colorimetry to identify high-risk features in culprit lesions of patients with acute coronary syndromes.
- Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention.
- Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction.
- Cardiometabolic risk and risk management. Introduction.
- Type 1 diabetes and coronary artery disease.
- The CHARISMA trial and the REACH registry outcomes.
- The Editor's roundtable: diabetes mellitus and coronary heart disease.
- Retroperitoneal hemorrhage from inferior epigastric artery: value of femoral angiography for detection and management.
- Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management: Response to Raggi et al.
- Antiplatelet therapy in populations at high risk of atherothrombosis.
- Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques.
- Gastric volvulus presenting as an acute coronary syndrome.
- Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?
- Prevalence of newly diagnosed diabetes in clinical settings.
- Diabetes, hyperglycemia, and the cardiologist: a call to action for optimizing care. Introduction.
- Impact of gender on in-hospital outcomes following contemporary percutaneous intervention for peripheral arterial disease.
- Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction.
- Managing cardiovascular risk inpatients with metabolic syndrome.
- Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
- Obesity: a major component of the metabolic syndrome.
- Correlation between cardiovascular disease and diabetes mellitus: current concepts.
- Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.
- Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
- Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque.
- Pharmacological treatment and prevention of heart failure in the diabetic patient.
- The platelet in diabetes: focus on prevention of ischemic events.
- Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types.
- Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.
- The relation of insulin resistance syndromes to risk of cardiovascular disease.
- Scholarly review of geometry and compliance: biomechanical perspectives on vascular injury and healing.
- Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications.
- Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
- Stress perfusion nuclear imaging in diabetes.
Schools
Tufts University School Of Medicine
Strong Memorial Hospital
Brigham Womens Hospital
Lahey Hospital amp Medical Center Executive Vice President
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Boston Magazine
- Fellow (FACC)
- Top MD
- Super Doctor
Education
-
Brigham and Women's Hospital -
University of Rochester -
Tufts University School of Medicine
Hospital
-
Lahey Hospital & Medical Center, Burlington
Drug Facts
| NPI NUMBER | 1033215264 | |
| NPPES Provider LastName | NESTO | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 018050001 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 865.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033215264 |
| Last Name Of The Provider | NESTO |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
Dr. David T. Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Suma A. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Gaasch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Paula M. Kinnunen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Barton, MD |
|
|
Dr. Lauren G. Gilstrap, MD |
|
Dr. Michael S. Levy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David M. Venesy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Fleet, MD |